|
17.30 |
|
Freie Vorträge I
Vorsitz: Sebastian Harder, Frankfurt
- Joachim Siegert, Dresden
First Results of a First in Man Proof of Concept Study of an Anti-CD4mAb-Fragment
for the Imaging of Chronic Inflammation in Patients with Active Rheumatoid Arthritis - Jörn Lötsch, Frankfurt
Differential opioid action on sensory and affective cerebral pain processing assessed
by functional magnet resonance imaging
- Susanne Greulich, Heidelberg
Are you familiar with your medication? Results of a knowledge test on Marcumar®
- Uwe Schüly, Biberach
Pharmacokinetic/pharmacodynamic modelling as a tool to define safe dosing regimens
for evaluation of dose response of tanogitran (BIBT 986)
|
|
Freie Vorträge II
Vorsitz: Uwe Fuhr, Köln
- Mike Ufer, Kiel
Impact of CYP3A4, CYP3A5 and ABCB1 genotype and intestinal expression on the pharmacokinetics
of budesonide
- Thomas Solbach, Erlangen
Altered ATP-binding cassette transporters in human heart failiure: Impact on channel
conductivity and drug-disposition
- Stefan V. Vormfelde, Göttingen
OATP1B1 polymorphisms and torsemide pharmacokinetics and harmacodynamics
- Elisabeth Butzer, Heidelberg
Enterohepatic circulation of the THC-metabolite 11-nor-9-carboxy-Δ9-tetrahydrocannabiol
(CTHC) after i.v. administration of CTHC in healthy human subjects
|
|
|